{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:22:22Z","timestamp":1776424942257,"version":"3.51.2"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Chonnam National University Hospital Biomedical Research Institute","award":["HCRI25033"],"award-info":[{"award-number":["HCRI25033"]}]},{"name":"Chonnam National University Hospital Biomedical Research Institute","award":["HCRI25039"],"award-info":[{"award-number":["HCRI25039"]}]},{"name":"Chonnam National University, South Korea","award":["2024-0438"],"award-info":[{"award-number":["2024-0438"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s11060-026-05476-9","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T13:37:50Z","timestamp":1771594670000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["HER2 heterogeneity between primary cancers and brain metastases: a retrospective analysis of 185 matched pairs across multiple cancer types"],"prefix":"10.1007","volume":"177","author":[{"given":"Ji Young","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joo Yeon","family":"Koo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nah Ihm","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Sun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun\u2011Jeong","family":"Shim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Hee","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roo Ji","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sue Jee","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae-Young","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Sub","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Hwa","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"key":"5476_CR1","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1158\/1078-0432.Ccr-22-0283","volume":"29","author":"KPS Raghav","year":"2023","unstructured":"Raghav KPS, Moasser MM (2023) Molecular Pathways and Mechanisms of HER2 in Cancer Therapy. Clin Cancer Res 29:2351\u20132361. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-22-0283","journal-title":"Clin Cancer Res"},{"key":"5476_CR2","doi-asserted-by":"publisher","unstructured":"Cheng X (2024) A Comprehensive Review of HER2 in Cancer Biology and Therapeutics. Genes (Basel) 15. https:\/\/doi.org\/10.3390\/genes15070903","DOI":"10.3390\/genes15070903"},{"key":"5476_CR3","doi-asserted-by":"publisher","first-page":"445","DOI":"10.5306\/wjco.v14.i11.445","volume":"14","author":"YR Chen","year":"2023","unstructured":"Chen YR, Xu ZX, Jiang LX, Dong ZW, Yu PF, Zhang Z, Gu GL (2023) Analysis of clinicopathological features and prognostic factors of breast cancer brain metastasis. World J Clin Oncol 14:445\u2013458. https:\/\/doi.org\/10.5306\/wjco.v14.i11.445","journal-title":"World J Clin Oncol"},{"key":"5476_CR4","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ejca.2022.12.019","volume":"181","author":"PC Chen","year":"2023","unstructured":"Chen PC, Yeh YM, Chu CT, Su PF, Chiu PH, Lin BW, Chen SH, Lin PC, Lee CT, Chen HHW, Chen CC (2023) HER2 amplification in colorectal cancer with brain metastasis: A propensity score matching study. Eur J Cancer 181:62\u201369. https:\/\/doi.org\/10.1016\/j.ejca.2022.12.019","journal-title":"Eur J Cancer"},{"key":"5476_CR5","doi-asserted-by":"publisher","unstructured":"Tincknell G, Naveed A, Nankervis J, Mukhtiar A, Piper AK, Becker TM, Chantrill L, Aghmesheh M, Vine KL, Ranson M, Brungs D (2022) HER2-Positive Gastroesophageal Cancers Are Associated with a Higher Risk of Brain Metastasis. Cancers (Basel) 14. https:\/\/doi.org\/10.3390\/cancers14235754","DOI":"10.3390\/cancers14235754"},{"key":"5476_CR6","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s12094-023-03306-2","volume":"26","author":"MY Lai","year":"2024","unstructured":"Lai MY, Guan WL, Yang J, Sun YT, Lu SX, Yang LQ, Yang DJ, Qiu MZ (2024) The relationship between brain metastasis and HER2 expression status in gastric cancer. Clin Transl Oncol 26:765\u2013773. https:\/\/doi.org\/10.1007\/s12094-023-03306-2","journal-title":"Clin Transl Oncol"},{"key":"5476_CR7","doi-asserted-by":"publisher","first-page":"4244","DOI":"10.1038\/onc.2015.489","volume":"35","author":"S Ingthorsson","year":"2016","unstructured":"Ingthorsson S, Andersen K, Hilmarsdottir B, Maelandsmo GM, Magnusson MK, Gudjonsson T (2016) HER2 induced EMT and tumorigenicity in breast epithelial progenitor cells is inhibited by coexpression of EGFR. Oncogene 35:4244\u20134255. https:\/\/doi.org\/10.1038\/onc.2015.489","journal-title":"Oncogene"},{"key":"5476_CR8","doi-asserted-by":"publisher","first-page":"811","DOI":"10.31557\/apjcp.2021.22.3.811","volume":"22","author":"E Jafari","year":"2021","unstructured":"Jafari E, Safinejad S, Dabiri S, Naghibzadeh-Tahami A (2021) Study of the Relationship between MMP-2 and MMP-9 and Her2\/neu Overexpression in Gastric Cancer: Clinico- Pathological Correlations. Asian Pac J Cancer Prev 22:811\u2013817. https:\/\/doi.org\/10.31557\/apjcp.2021.22.3.811","journal-title":"Asian Pac J Cancer Prev"},{"key":"5476_CR9","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1200\/jco.22.02864","volume":"41","author":"AC Wolff","year":"2023","unstructured":"Wolff AC, Somerfield MR, Dowsett M, Hammond MEH, Hayes DF, McShane LM, Saphner TJ, Spears PA, Allison KH (2023) Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO-College of American Pathologists Guideline Update. J Clin Oncol 41:3867\u20133872. https:\/\/doi.org\/10.1200\/jco.22.02864","journal-title":"J Clin Oncol"},{"key":"5476_CR10","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/s0140-6736(10)61121-x","volume":"376","author":"YJ Bang","year":"2010","unstructured":"Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T, Aprile G, Kulikov E, Hill J, Lehle M, R\u00fcschoff J, Kang YK (2010) Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 376:687\u2013697. https:\/\/doi.org\/10.1016\/s0140-6736(10)61121-x","journal-title":"Lancet"},{"key":"5476_CR11","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1038\/modpathol.2015.98","volume":"28","author":"E Valtorta","year":"2015","unstructured":"Valtorta E, Martino C, Sartore-Bianchi A, Penaullt-Llorca F, Viale G, Risio M, Rugge M, Grigioni W, Bencardino K, Lonardi S, Zagonel V, Leone F, Noe J, Ciardiello F, Pinto C, Labianca R, Mosconi S, Graiff C, Aprile G, Frau B, Garufi C, Loupakis F, Racca P, Tonini G, Lauricella C, Veronese S, Truini M, Siena S, Marsoni S, Gambacorta M (2015) Assessment of a HER2 scoring system for colorectal cancer: results from a validation study. Mod Pathol 28:1481\u20131491. https:\/\/doi.org\/10.1038\/modpathol.2015.98","journal-title":"Mod Pathol"},{"key":"5476_CR12","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1093\/neuonc\/nox077","volume":"19","author":"DN Cagney","year":"2017","unstructured":"Cagney DN, Martin AM, Catalano PJ, Redig AJ, Lin NU, Lee EQ, Wen PY, Dunn IF, Bi WL, Weiss SE, Haas-Kogan DA, Alexander BM, Aizer AA (2017) Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study. Neuro Oncol 19:1511\u20131521. https:\/\/doi.org\/10.1093\/neuonc\/nox077","journal-title":"Neuro Oncol"},{"key":"5476_CR13","doi-asserted-by":"publisher","first-page":"vdab010","DOI":"10.1093\/noajnl\/vdab010","volume":"3","author":"R Kotecha","year":"2021","unstructured":"Kotecha R, Tonse R, Rubens M, McDermott MW, Odia Y, Appel H, Mehta MP (2021) Systematic review and meta-analysis of breast cancer brain metastasis and primary tumor receptor expression discordance. Neurooncol Adv 3:vdab010. https:\/\/doi.org\/10.1093\/noajnl\/vdab010","journal-title":"Neurooncol Adv"},{"key":"5476_CR14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.breast.2019.10.007","volume":"49","author":"JS Kim","year":"2020","unstructured":"Kim JS, Kim K, Jung W, Shin KH, Im SA, Kim HJ, Kim YB, Chang JS, Choi DH, Park YH, Kim DY, Kim TH, Choi BO, Lee SW, Kim S, Kwon J, Kang KM, Chung WK, Kim KS, Nam JH, Yoon WS, Kim JH, Cha J, Oh YK, Kim IA (2020) Survival outcomes of breast cancer patients with brain metastases: A multicenter retrospective study in Korea (KROG 16\u2009\u2013\u200912). Breast 49:41\u201347. https:\/\/doi.org\/10.1016\/j.breast.2019.10.007","journal-title":"Breast"},{"key":"5476_CR15","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1038\/s41416-023-02569-4","volume":"130","author":"AA Prete","year":"2024","unstructured":"Prete AA, Angerilli V, Bergamo F, Vettore V, De Toni C, Intini R, Cerma K, Ricagno G, Cerantola R, Perissinotto E, De Rosa A, Ceccon C, Gasparello J, Denaro L, D\u2019Amico A, Chioffi F, Carcea E, Fassan M, Lonardi S (2024) HER2 expression and genOmic characterization of rESected brain metastases from colorectal cancer: the HEROES study. Br J Cancer 130:1316\u20131323. https:\/\/doi.org\/10.1038\/s41416-023-02569-4","journal-title":"Br J Cancer"},{"key":"5476_CR16","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/cam4.228","volume":"3","author":"WS Lee","year":"2014","unstructured":"Lee WS, Park YH, Lee JN, Baek JH, Lee TH, Ha SY (2014) Comparison of HER2 expression between primary colorectal cancer and their corresponding metastases. Cancer Med 3:674\u2013680. https:\/\/doi.org\/10.1002\/cam4.228","journal-title":"Cancer Med"},{"key":"5476_CR17","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1158\/2159-8290.Cd-12-0108","volume":"2","author":"K Takezawa","year":"2012","unstructured":"Takezawa K, Pirazzoli V, Arcila ME, Nebhan CA, Song X, de Stanchina E, Ohashi K, Janjigian YY, Spitzler PJ, Melnick MA, Riely GJ, Kris MG, Miller VA, Ladanyi M, Politi K, Pao W (2012) HER2 amplification: a potential mechanism of acquired resistance to EGFR inhibition in EGFR-mutant lung cancers that lack the second-site EGFRT790M mutation. Cancer Discov 2:922\u2013933. https:\/\/doi.org\/10.1158\/2159-8290.Cd-12-0108","journal-title":"Cancer Discov"},{"key":"5476_CR18","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1158\/1078-0432.Ccr-12-2246","volume":"19","author":"HA Yu","year":"2013","unstructured":"Yu HA, Arcila ME, Rekhtman N, Sima CS, Zakowski MF, Pao W, Kris MG, Miller VA, Ladanyi M, Riely GJ (2013) Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers. Clin Cancer Res 19:2240\u20132247. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-12-2246","journal-title":"Clin Cancer Res"},{"key":"5476_CR19","doi-asserted-by":"publisher","first-page":"152082","DOI":"10.1016\/j.anndiagpath.2022.152082","volume":"63","author":"M Demleitner","year":"2023","unstructured":"Demleitner M, Erlenbach-Wunsch K, Coras R, Erber R, Polifka I, Eyupoglu I, Fuchs F, Hartmann A, Agaimy A (2023) Lung cancer presenting with central nervous system metastasis: Clinicopathological and molecular analysis of 171 cases. Ann Diagn Pathol 63:152082. https:\/\/doi.org\/10.1016\/j.anndiagpath.2022.152082","journal-title":"Ann Diagn Pathol"},{"key":"5476_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4149\/neo_2011_01_27","volume":"58","author":"JS Koo","year":"2011","unstructured":"Koo JS, Kim SH (2011) EGFR and HER-2 status of non-small cell lung cancer brain metastasis and corresponding primary tumor. Neoplasma 58:27\u201334. https:\/\/doi.org\/10.4149\/neo_2011_01_27","journal-title":"Neoplasma"},{"key":"5476_CR21","doi-asserted-by":"publisher","first-page":"vdad080","DOI":"10.1093\/noajnl\/vdad080","volume":"5","author":"JK Tabor","year":"2023","unstructured":"Tabor JK, Onoichenco A, Narayan V, Wernicke AG, D\u2019Amico RS, Vojnic M (2023) Brain metastasis screening in the molecular age. Neurooncol Adv 5:vdad080. https:\/\/doi.org\/10.1093\/noajnl\/vdad080","journal-title":"Neurooncol Adv"},{"key":"5476_CR22","doi-asserted-by":"publisher","first-page":"e1274","DOI":"10.1002\/cnr2.1274","volume":"5","author":"AS Zimmer","year":"2022","unstructured":"Zimmer AS, Van Swearingen AED, Anders CK (2022) HER2-positive breast cancer brain metastasis: A new and exciting landscape. Cancer Rep (Hoboken) 5:e1274. https:\/\/doi.org\/10.1002\/cnr2.1274","journal-title":"Cancer Rep (Hoboken)"},{"key":"5476_CR23","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41523-023-00592-5","volume":"9","author":"NS Moss","year":"2023","unstructured":"Moss NS, Singh JM, Reiner AS, Drago JZ, Modi S, Seidman AD, Chandarlapaty S, Ross DS (2023) Incidence of HER2-expressing brain metastases in patients with HER2-null breast cancer: a matched case analysis. NPJ Breast Cancer 9:86. https:\/\/doi.org\/10.1038\/s41523-023-00592-5","journal-title":"NPJ Breast Cancer"},{"key":"5476_CR24","unstructured":"Rakha EA, Ellis KHAIO, Horii R, Masuda S, Penault-Llorca F, Tsuda H, Vicent-Salomon A (2019) Invasive breast carcinoma: General overview. In: Lokuhetty D, Watanabe VAWR, Cree IA (eds) Breast Tumours, 5th edn. International Agency for Research on Cancer Lyon, pp 82\u2013101"},{"key":"5476_CR25","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.critrevonc.2009.09.002","volume":"76","author":"CA Parise","year":"2010","unstructured":"Parise CA, Bauer KR, Caggiano V (2010) Variation in breast cancer subtypes with age and race\/ethnicity. Crit Rev Oncol Hematol 76:44\u201352. https:\/\/doi.org\/10.1016\/j.critrevonc.2009.09.002","journal-title":"Crit Rev Oncol Hematol"},{"key":"5476_CR26","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s11060-018-2798-4","volume":"138","author":"D Limon","year":"2018","unstructured":"Limon D, Gal O, Gordon N, Katz L, Perl G, Purim O, Amit L, Stemmer SM, Kundel Y, Ben-Aharon I, Brenner B, Siegal T, Yust-Katz S (2018) Brain metastasis in gastroesophageal adenocarcinoma and HER2 status. J Neurooncol 138:315\u2013320. https:\/\/doi.org\/10.1007\/s11060-018-2798-4","journal-title":"J Neurooncol"},{"key":"5476_CR27","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1001\/jamaoncol.2016.5630","volume":"3","author":"N Priedigkeit","year":"2017","unstructured":"Priedigkeit N, Hartmaier RJ, Chen Y, Vareslija D, Basudan A, Watters RJ, Thomas R, Leone JP, Lucas PC, Bhargava R, Hamilton RL, Chmielecki J, Puhalla SL, Davidson NE, Oesterreich S, Brufsky AM, Young L, Lee AV (2017) Intrinsic Subtype Switching and Acquired ERBB2\/HER2 Amplifications and Mutations in Breast Cancer Brain Metastases. JAMA Oncol 3:666\u2013671. https:\/\/doi.org\/10.1001\/jamaoncol.2016.5630","journal-title":"JAMA Oncol"},{"key":"5476_CR28","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/s41379-021-00738-5","volume":"34","author":"A Katayama","year":"2021","unstructured":"Katayama A, Miligy IM, Shiino S, Toss MS, Eldib K, Kurozumi S, Quinn CM, Badr N, Murray C, Provenzano E, Callagy G, Martyn C, Millican-Slater R, Purdie C, Purnell D, Pinder SE, Oyama T, Shaaban AM, Ellis I, Lee AHS, Rakha EA (2021) Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancer. Mod Pathol 34:1271\u20131281. https:\/\/doi.org\/10.1038\/s41379-021-00738-5","journal-title":"Mod Pathol"},{"key":"5476_CR29","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/path.6230","volume":"262","author":"MH Chui","year":"2024","unstructured":"Chui MH, Brown DN, Da Cruz Paula A, da Silva EM, Momeni-Boroujeni A, Reis-Filho JS, Zhang Y, Makker V, Ellenson LH, Weigelt B (2024) Decreased HER2 expression in endometrial cancer following anti-HER2 therapy. J Pathol 262:129\u2013136. https:\/\/doi.org\/10.1002\/path.6230","journal-title":"J Pathol"},{"key":"5476_CR30","doi-asserted-by":"publisher","first-page":"75","DOI":"10.21873\/anticanres.13927","volume":"40","author":"T Kijima","year":"2020","unstructured":"Kijima T, Arigami T, Uenosono Y, Hiraki T, Yanagita S, Matsushita D, Okubo K, Shimonosono M, Ishigami S, Maemura K, Tanimoto A, Natsugoe S (2020) Comparison of HER2 Status Before and After Trastuzumab-based Chemotherapy in Patients With Advanced Gastric Cancer. Anticancer Res 40:75\u201380. https:\/\/doi.org\/10.21873\/anticanres.13927","journal-title":"Anticancer Res"},{"key":"5476_CR31","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1038\/s41591-022-01935-8","volume":"28","author":"R Bartsch","year":"2022","unstructured":"Bartsch R, Berghoff AS, Furtner J, Marhold M, Bergen ES, Roider-Schur S, Starzer AM, Forstner H, Rottenmanner B, Dieckmann K, Bago-Horvath Z, Haslacher H, Widhalm G, Ilhan-Mutlu A, Minichsdorfer C, Fuereder T, Szekeres T, Oehler L, Gruenberger B, Singer CF, Weltermann A, Puhr R, Preusser M (2022) Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial. Nat Med 28:1840\u20131847. https:\/\/doi.org\/10.1038\/s41591-022-01935-8","journal-title":"Nat Med"},{"key":"5476_CR32","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.annonc.2021.12.005","volume":"33","author":"G Curigliano","year":"2022","unstructured":"Curigliano G, Mueller V, Borges V, Hamilton E, Hurvitz S, Loi S, Murthy R, Okines A, Paplomata E, Cameron D, Carey LA, Gelmon K, Hortobagyi GN, Krop I, Loibl S, Pegram M, Slamon D, Ramos J, Feng W, Winer E (2022) Tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2\u2009+\u2009metastatic breast cancer with and without brain metastases (HER2CLIMB): final overall survival analysis. Ann Oncol 33:321\u2013329. https:\/\/doi.org\/10.1016\/j.annonc.2021.12.005","journal-title":"Ann Oncol"},{"key":"5476_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2203690","volume":"387","author":"S Modi","year":"2022","unstructured":"Modi S, Jacot W, Yamashita T, Sohn J, Vidal M, Tokunaga E, Tsurutani J, Ueno NT, Prat A, Chae YS, Lee KS, Niikura N, Park YH, Xu B, Wang X, Gil-Gil M, Li W, Pierga JY, Im SA, Moore HCF, Rugo HS, Yerushalmi R, Zagouri F, Gombos A, Kim SB, Liu Q, Luo T, Saura C, Schmid P, Sun T, Gambhire D, Yung L, Wang Y, Singh J, Vitazka P, Meinhardt G, Harbeck N, Cameron DA (2022) Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer. N Engl J Med 387:9\u201320. https:\/\/doi.org\/10.1056\/NEJMoa2203690","journal-title":"N Engl J Med"},{"key":"5476_CR34","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41523-021-00252-6","volume":"7","author":"T Grinda","year":"2021","unstructured":"Grinda T, Joyon N, Lusque A, Lefevre S, Arnould L, Penault-Llorca F, Macgrogan G, Treilleux I, Vincent-Salomon A, Haudebourg J, Maran-Gonzalez A, Charafe-Jauffret E, Courtinard C, Franchet C, Verriele V, Brain E, Tas P, Blanc-Fournier C, Leroux A, Loussouarn D, Berghian A, Brabencova E, Ghnassia JP, Scoazec JY, Delaloge S, Filleron T, Lacroix-Triki M (2021) Phenotypic discordance between primary and metastatic breast cancer in the large-scale real-life multicenter French ESME cohort. NPJ Breast Cancer 7:41. https:\/\/doi.org\/10.1038\/s41523-021-00252-6","journal-title":"NPJ Breast Cancer"},{"key":"5476_CR35","doi-asserted-by":"publisher","first-page":"103669","DOI":"10.1016\/j.breast.2023.103669","volume":"73","author":"H Xu","year":"2024","unstructured":"Xu H, Wang Y, Li L, Han Y, Wu Y, Sa Q, Xu B, Wang J (2024) New insights into HER2-low breast cancer brain metastasis: A retrospective analysis. Breast 73:103669. https:\/\/doi.org\/10.1016\/j.breast.2023.103669","journal-title":"Breast"},{"key":"5476_CR36","doi-asserted-by":"publisher","first-page":"e2228083","DOI":"10.1001\/jamanetworkopen.2022.28083","volume":"5","author":"C Tsai","year":"2022","unstructured":"Tsai C, Nguyen B, Luthra A, Chou JF, Feder L, Tang LH, Strong VE, Molena D, Jones DR, Coit DG, Ilson DH, Ku GY, Cowzer D, Cadley J, Capanu M, Schultz N, Beal K, Moss NS, Janjigian YY, Maron SB (2022) Outcomes and Molecular Features of Brain Metastasis in Gastroesophageal Adenocarcinoma. JAMA Netw Open 5:e2228083. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.28083","journal-title":"JAMA Netw Open"},{"key":"5476_CR37","doi-asserted-by":"publisher","first-page":"5787","DOI":"10.3892\/ol.2018.8054","volume":"15","author":"L Cavanna","year":"2018","unstructured":"Cavanna L, Seghini P, Di Nunzio C, Orlandi E, Michieletti E, Stroppa EM, Mordenti P, Citterio C, Vecchia S, Zangrandi A (2018) Gastric cancer with brain metastasis and the role of human epidermal growth factor 2 status. Oncol Lett 15:5787\u20135791. https:\/\/doi.org\/10.3892\/ol.2018.8054","journal-title":"Oncol Lett"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05476-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05476-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05476-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T08:37:17Z","timestamp":1776069437000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-026-05476-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["5476"],"URL":"https:\/\/doi.org\/10.1007\/s11060-026-05476-9","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"assertion":[{"value":"24 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Chonnam National University Hwasun Hospital (CNUHH-2024-114). Written informed consent to use clinical data and surgically resected specimens was obtained from all patients or their legal surrogates.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}